Lightning Round: RLI, Dendreon, Motricity and More

RLI : Cramer said he likes Prudential Financial more.

Dendreon : While Dendreon is “very controversial,” Cramer said, he thinks investors should hold onto it because of the company’s “breakthrough medical technology” for prostate cancer.

Motricity : Insider selling of newly unlocked shares has put pressure of MOTR, but Cramer thinks the stock is a buy. “It has come down way too much,” he said.

Diana Shipping : Cramer can’t recommend DSX given the glut of ships flooding the industry. That oversupply is killing day rates.

Molycorp : MCP has enjoyed a big run, so Cramer recommended taking profits on half a position and then letting the rest ride.

NovaGold Resources : “I think it’s the best long-term play on gold in the world,” Cramer said.

KBR : Cramer likes the infrastructure business right now, but he thinks Fluor is the better play.











When this story published, Cramer’s charitable trust owned Fluor, NovaGold Resources and Prudential Financial.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com